112 related articles for article (PubMed ID: 15691647)
1. Loss of Gelsolin expression in human ovarian carcinomas.
Noske A; Denkert C; Schober H; Sers C; Zhumabayeva B; Weichert W; Dietel M; Wiechen K
Eur J Cancer; 2005 Feb; 41(3):461-9. PubMed ID: 15691647
[TBL] [Abstract][Full Text] [Related]
2. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
[TBL] [Abstract][Full Text] [Related]
3. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
Wang P; Wu X; Chen W; Liu J; Wang X
Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
[TBL] [Abstract][Full Text] [Related]
5. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of death-associated protein kinase in human uterine and ovarian carcinoma cells.
Bai T; Tanaka T; Yukawa K; Maeda M; Umesaki N
Oncol Rep; 2004 Mar; 11(3):661-5. PubMed ID: 14767518
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene.
Wiechen K; Diatchenko L; Agoulnik A; Scharff KM; Schober H; Arlt K; Zhumabayeva B; Siebert PD; Dietel M; Schäfer R; Sers C
Am J Pathol; 2001 Nov; 159(5):1635-43. PubMed ID: 11696424
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas.
Arnold JM; Cummings M; Purdie D; Chenevix-Trench G
Br J Cancer; 2001 Nov; 85(9):1351-8. PubMed ID: 11720474
[TBL] [Abstract][Full Text] [Related]
9. RUNX3 protein is overexpressed in human epithelial ovarian cancer.
Nevadunsky NS; Barbieri JS; Kwong J; Merritt MA; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2009 Feb; 112(2):325-30. PubMed ID: 18937968
[TBL] [Abstract][Full Text] [Related]
10. High expression of tissue inhibitor of metalloproteinase-2 in serous ovarian carcinomas and the role of this expression in ovarian tumorigenesis.
Kim TJ; Rho SB; Choi YL; Choi CH; Lee JW; Bae DS; Ahn G; Lee JH; Kim BG
Hum Pathol; 2006 Jul; 37(7):906-13. PubMed ID: 16784992
[TBL] [Abstract][Full Text] [Related]
11. EphA2 expression is associated with aggressive features in ovarian carcinoma.
Thaker PH; Deavers M; Celestino J; Thornton A; Fletcher MS; Landen CN; Kinch MS; Kiener PA; Sood AK
Clin Cancer Res; 2004 Aug; 10(15):5145-50. PubMed ID: 15297418
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
[TBL] [Abstract][Full Text] [Related]
13. Gelsolin: a candidate for suppressor of human bladder cancer.
Tanaka M; Müllauer L; Ogiso Y; Fujita H; Moriya S; Furuuchi K; Harabayashi T; Shinohara N; Koyanagi T; Kuzumaki N
Cancer Res; 1995 Aug; 55(15):3228-32. PubMed ID: 7614452
[TBL] [Abstract][Full Text] [Related]
14. Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis.
Castellvi J; Garcia A; de la Torre J; Hernandez J; Gil A; Xercavins J; Ramón y Cajal S
Hum Pathol; 2006 Jul; 37(7):883-9. PubMed ID: 16784989
[TBL] [Abstract][Full Text] [Related]
15. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
[TBL] [Abstract][Full Text] [Related]
16. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
[TBL] [Abstract][Full Text] [Related]
17. Loss of cellular retinol-binding protein 1 gene expression in microdissected human ovarian cancer.
Cvetković D; Williams SJ; Hamilton TC
Clin Cancer Res; 2003 Mar; 9(3):1013-20. PubMed ID: 12631600
[TBL] [Abstract][Full Text] [Related]
18. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
[TBL] [Abstract][Full Text] [Related]
19. Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells.
Syed V; Zhang X; Lau KM; Cheng R; Mukherjee K; Ho SM
Oncogene; 2005 Dec; 24(55):8128-43. PubMed ID: 16116479
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
